Skip to main content
Premium Trial:

Request an Annual Quote

Rubicon Genomics to Develop MethylPlex Tool for Prostate and Bladder Cancers

NEW YORK, Oct. 31 (GenomeWeb News) - Rubicon Genomics will work with Abbott Molecular to develop and sell its MethylPlex tool for detecting prostate and bladder cancers, Rubicon said today.

 

A methylation detection technology, MethylPlex detects patterns of abnormal DNA methylation in serum and urine during tumor formation and progression. Under the agreement, the tests will combine proprietary Rubicon methylation markers and a simplified method to detect them.

 

Abbott Molecular is a division of Abbott. Financial details for this agreement were not disclosed.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.